What is Prilenia?
Prilenia is a biotechnology services provider.
What does Prilenia do?
The company develops treatments for neurodegenerative and neurodevelopmental disorders.
Who owns Prilenia?
Michael R Hayden founded Prilenia in 2018.
How much has Prilenia raised?
The company picked up $43 million in a Series B funding round that brings the company’s total financing to $105.5 million in funding over 2 rounds.
Who has invested in Prilenia?
ALS Investment Fund and 6 other investors backed the latest investment round.
What domain name does Prilenia operate on?
You can see Prilenia mean business by looking at their domain name choices – the brand has secured Prilenia.com, an exact brand match name with the global .com extension.